title: National Institues of Health recommends the routine use of H2 blockers in preterm infants be carefully evaluated.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Pulsifer-Anderson
authors.forename: Ronnie
authors.initials: R
authors.lastname: Guillet
mesh_terms: D020345:Enterocolitis, Necrotizing / Q000139:chemically induced* / Q000451:nursing; D005260:Female; D006635:Histamine H2 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D019102:Infant, Very Low Birth Weight; D009316:National Institutes of Health (U.S.); D017283:Neonatal Nursing / Q000379:methods*; D014481:United States
chemical_list: D006635:Histamine H2 Antagonists